Grant & Award Opportunities - Stand Up To Cancer

Grant & Award Opportunities

Are you a researcher who is looking for funding to carry out impactful and innovative research?

Stand Up To Cancer (SU2C) grants and awards fund cancer research projects that address critical problems in patient care and deliver near-term patient benefit through both individual and collaborative teams of expert investigators.

We are also committed to actively changing the health disparities landscape by supporting research and clinical trials that will develop successful strategies, measurable outcomes, and robust outreach to historically underrepresented racial and ethnic minority populations.

Core Principles

Patients can’t wait for new breakthroughs so SU2C does not operate on traditional grant cycles; rather we open Request For Applications (RFAs) as soon as funds are available. The core principles that guide our application selection process include:

  • Maximizing innovation while minimizing bureaucracy
  • Collaboration over competition
  • Advancing Health Equity in project goals and in grantee team makeup
  • Team environment to facilitate information sharing
  • Goal-oriented projects with defined milestones and deliverables
  • Regular progress reviews

Stand Up To Cancer is committed to eliminating barriers of access to new treatments for all cancer patients by harnessing the promise of precision medicine inclusive of diverse patient populations. We support clinical trials and research studies that have developed successful strategies, measurable outcomes, and robust outreach plans to include historically underrepresented racial and ethnic minority populations. We have developed application resources for incorporating health equity principles into research projects.

Open Applications

Stand Up To Cancer strongly encourages novel, collaborative, and high-impact proposals. Proposals submitted in response to Requests for Applications (RFAs) are rigorously reviewed, and the most promising, exciting projects are selected by blue ribbon committees.


Stand Up To Cancer (SU2C) Nina Nicolai Innovation in Collaboration Award

The Stand Up To Cancer (SU2C) Nina Nicolai Innovation in Collaboration Award is available to members of the SU2C scientific community to explore synergistic and innovative collaborations that enhance the SU2C mission to accelerate the development of new cancer treatments for pancreatic cancer. Emphasis will be placed on submissions that involve new SU2C collaborations.


  • At least one of the Co-leaders must be an Early Career Investigator.*
  • At least one of the applicants must be affiliated with an academic, medical, or research institution.
  • Industry applicants, non-profit applicants, and applicants from governmental agencies are eligible to apply but are not eligible to receive funds.
  • Both you and your Co-leader are submitting only 1 application.

*Early Career Investigators are defined as junior faculty (e.g. independent investigators who have completed their training within the past seven years), postdoctoral fellows, clinical research fellows, or other researchers-in-training who are working under the direction of a scientific mentor.

Selection Process: The recipients will be selected by a committee comprised of SU2C Scientific Advisory Committee Members, based on ideas submitted by eligible applicants. The selected recipients must provide a one-page project description, a budget, and a budget justification for the collaborative research to be funded. The SAC Executive Committee will review these materials and may provide comments and suggestions to the recipients. Funding is contingent upon SU2C approval of the final project and budget.

Award Amount: Depending on the scope of the project, up to $225,000 will be available for a period of 1-2 years.

Requirements: The grantees will be required to submit progress and financial reports annually to SU2C in advance of the SU2C Scientific Summit (reports due no later than January 15 of each year) and may also be asked to provide a brief update of their funded research to the SU2C community during a subsequent SU2C Scientific Summit.

Application Submission: You may submit applications through Proposal Central by clicking on the link below. The application window will be open from Tuesday, March 12, 2024 through Friday, April 12, 2024.

Questions: Please email any questions to

Upcoming Areas of Interest

SU2C is interested in funding innovative research that has the potential to deliver life-saving results to all patients near-term, and supporting collaborations that focus on research in specific diseases or therapeutic approaches.

Areas of interest are best identified by our scientific leadership, strategic imperatives, and existing and emerging collaborations are ripe for breakthroughs that provide the most benefit to patients in the near term.


When new areas of research are identified that could have significant patient impact and potential for breakthrough, SU2C acts quickly to push proposals in these areas from concept to reality. SU2C’s research teams study many cancer types, with a focus on today’s most innovative areas of cancer detection and therapy.


Pancreatic Cancer (19.5%)Leukemia/Leukaemia (7%)Lung Cancer (14.5%)Melanoma (5%)Breast Cancer (13%)Brain Tumor (3%)Not-Site Specific Cancer (10%)Ovarian Cancer (3%)Colon and Rectal Cancer (7%)Endometrial (2%)Prostate Cancer (8%)*Other Cancers (6%)

*Other Cancers (6%)

NeuroblastomaGenital System, MaleKidneyMyelomaNon-Hodgkin’s LymphomaGenital System, FemaleUrinary TractAnal CancerLiverSarcoma (soft-tissue)Cervical CancerLaryngealBone CancerGastrointestinalPharyngeal

Progress against one cancer is progress against all cancers.
See what SU2C scientists are working on now.



If you are a researcher looking for funding to carry out impactful and innovative research, sign up below for updates on grant opportunities, and follow @SU2CScience on Twitter.

   Please leave this field empty
Please validate the captcha

For more information on our grants, or your application, please email

Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.